Yes. The regulation, “Labeling for in vitro diagnostic products,” (21 CFR
809.10), specifies the information required on labeling and in package inserts of
marketed products as well as products in development that are distributed for use
in studies. We recommend that you design IVD studies so that the results will
support the proposed indications for use in the package insert and labeling.
